BRISTAR IMMUNOTECH Trademark
Trademark Overview
On Thursday, May 4, 2023, a trademark application was filed for BRISTAR IMMUNOTECH with the United States Patent and Trademark Office. The USPTO has given the BRISTAR IMMUNOTECH trademark a serial number of 79374147. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, September 30, 2024. This trademark is owned by BRISTAR IMMUNOTECH LIMITED. The BRISTAR IMMUNOTECH trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Blood products; medicines for human purposes; pharmaceutical preparations; drugs for medical purposes; blood for medical purposes; biological preparations for medical purposes; stem cells for medical purposes; immunostimulants; injectable medicinal solutions; biochemical medicines
Health care; nursing, medical; telemedicine services; medical assistance; medical clinic services; hospital services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; human tissue bank services; blood bank services; therapy services
General Information
Serial Number | 79374147 |
Word Mark | BRISTAR IMMUNOTECH |
Filing Date | Thursday, May 4, 2023 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Monday, September 30, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Blood products; medicines for human purposes; pharmaceutical preparations; drugs for medical purposes; blood for medical purposes; biological preparations for medical purposes; stem cells for medical purposes; immunostimulants; injectable medicinal solutions; biochemical medicines |
Goods and Services | Health care; nursing, medical; telemedicine services; medical assistance; medical clinic services; hospital services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; human tissue bank services; blood bank services; therapy services |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, July 14, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, July 14, 2023 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | BRISTAR IMMUNOTECH LIMITED |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | CN |
Trademark Events
Event Date | Event Description |
Tuesday, July 18, 2023 | APPLICATION FILING RECEIPT MAILED |
Thursday, July 13, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Friday, July 14, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, January 30, 2024 | ASSIGNED TO EXAMINER |
Monday, September 30, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Monday, September 30, 2024 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Monday, March 18, 2024 | REFUSAL PROCESSED BY IB |
Tuesday, February 6, 2024 | NON-FINAL ACTION WRITTEN |
Wednesday, February 7, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Wednesday, February 28, 2024 | REFUSAL PROCESSED BY MPU |
Wednesday, February 28, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |